Evaluate the effectiveness of two Unani medicines in the treatment of piles

Comparative Evaluation of Efficacy Of habb e Sandroos and habb e Rasuat In Internal Hemorrhoids - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079065

Enrollment

Registered

2025-01-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K648- Other hemorrhoids

Interventions

Intervention1: HABB-e-SANDROOS orally 2 pills each weighing 500mg thrice a day for 28 days: HABB-e-SANDROOS will be prepared by following ingredients 1) Sandroos(Trachylobium hornemannianum 2) Shitraj

Eligibility

Inclusion criteria

Inclusion criteria: 1) Diagnosed case of internal haemorrhoids grade 1 and 2 2) Patients who have agreed to sign the informed consent form and follow up the protocol

Exclusion criteria

Exclusion criteria: 1) External Pile mass 2) Severe systemic illness including IBD, Liver cirrhosis Portal Hypertension 3) Pregnant and lactating women 4) Haemorrhoids associated with other Anorectal diseases like rectal polyp, Fissure in Another,Fistula in Another,Carcinoma of Rectum and Anal , STDs

Design outcomes

Primary

Measure	Time frame
Reduction in mass and bleeding per RectumTimepoint: 28 days	—

Secondary

Measure	Time frame
Per Rectal Mucus discharge Perianal Itching Defecation discomfortTimepoint: 28 days	—

Countries

India

Contacts

Public ContactMehjabeen Fatimah

National Institute of Unani Medicine

fatimahmehjabeen@gmail.com8057438462

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026